Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

Front Oncol. 2024 Apr 18:14:1397607. doi: 10.3389/fonc.2024.1397607. eCollection 2024.

Mojtaba Azari^{1

2}, Maryam Barkhordar^{1

2}, Tanaz Bahri^{1

2}, Soroush Rad^{2

3}, Hosein Kamranzadeh Fumani^{2

4}, Seied Asadollah Mousavi^{1

2}, Sahar Tavakoli Shiraji^{2

4}, Morteza Azari^{1

2}, Parisa Shafaroudi^{1

2}, Mohammad Vaezi^{2

3}

¹ Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
² Research Institute for Oncology, Hematology, and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
³ Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
⁴ Hematologic Malignancies Research Center, Tehran University of Medical Science, Tehran, Iran.

Abstract

[This corrects the article DOI: 10.3389/fonc.2024.1339605.].

Keywords: donor parity; graft-versus-host disease (GVHD); hematopoietic stem cell transplantation (HSCT); overall survival; relapse incidence.